MediFind

Find a Doctor

Serena Di Cosimo

Fondazione Irccs Istituto Nazionale Dei Tumori
Female

Bio


Serena Di Cosimo is in Milan, Italy. They have been an author on 133 peer reviewed articles in the past 15 years. Dr. Di Cosimo's top three areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, and Triple-Negative Breast Cancer.

Contact

Milan, IT

Latest Research


Latest Advance
Study
  • Condition: HER2+ breast cancer
  • Journal: Breast cancer research : BCR
  • Treatment Used: Paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab
  • Number of Patients: 0
  • Published —
The study researched the effects of paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab for HER2+ breast cancer.
Latest Advance
Study
  • Condition: Triple Negative Breast Cancer
  • Journal: PloS one
  • Treatment Used: Neoadjuvant Eribulin Mesylate Following Anthracycline and Taxane
  • Number of Patients: 13
  • Published —
This study determined whether eribulin mesylate (E) could also benefit patients with primary triple negative breast cancer ?2 cm eligible for neoadjuvant chemotherapy.
Latest Advance
Study
  • Condition: HER2-Positive Primary Breast Cancer
  • Journal: European journal of cancer (Oxford, England : 1990)
  • Treatment Used: Lapatinib vs. Lapatinib + Trastuzumab vs. Trastuzumab
  • Number of Patients: 455
  • Published —
The purpose of this study was to compare the effectiveness of lapatinib alone versus lapatinib plus trastuzumab versus trastuzumab alone in patients with HER2-positive primary breast cancer.

Clinical Trials


This doctor has not participated in any recent clinical trials.

All Publications
View All


Contact

Milan, IT

Insurance

Contact them to find out if they accept your insurance plan.